3-FPM: Difference between revisions
>Kenan m Use stimulants template |
>TheMunchinator m I included anecdotal reports of serious flu-like, inflammatory/vasculitis symptoms to the toxicity section. I believe this is important as several users of Reddit and Bluelight have reported this and I personally have experienced it from 100mg oral dose. |
||
Line 2: | Line 2: | ||
{{SubstanceBox/3-FPM}} | {{SubstanceBox/3-FPM}} | ||
'''3-Fluorophenmetrazine''' (also known as '''3F-Phenmetrazine''', '''PAL-593''', and '''3-FPM''') is a novel [[psychoactive class::stimulant]] substance of the [[Chemical class::phenylmorpholine]] class. 3-FPM is a derivative of [[phenmetrazine]], a once-popular stimulant substance that was clinically used as an anorectic in Europe in the 1950s.<ref> Kalant, Oriana Josseau (1966). The Amphetamines: Toxicity and Addiction. ISBN 0-398-02511-8.</ref> It produces its activity by increasing the levels of [[serotonin]], [[dopamine]], and [[norepinephrine]] in the brain. | '''3-Fluorophenmetrazine''' (also known as '''3F-Phenmetrazine''', '''PAL-593''', and '''3-FPM''') is a novel [[psychoactive class::stimulant]] substance of the [[Chemical class::phenylmorpholine]] class. 3-FPM is a derivative of [[phenmetrazine]], a once-popular stimulant substance that was clinically used as an anorectic in Europe in the 1950s.<ref>Kalant, Oriana Josseau (1966). The Amphetamines: Toxicity and Addiction. ISBN 0-398-02511-8.</ref> It produces its activity by increasing the levels of [[serotonin]], [[dopamine]], and [[norepinephrine]] in the brain. | ||
The synthesis and pharmacology of 3-FPM was first reported in a patent filed in 2011.<ref>Blough, B. E., Rothman, R., Landavazo, A., Page, K. M., & Decker, A. M. (2017). U.S. Patent No. 9,617,229. Washington, DC: U.S. Patent and Trademark Office.</ref> Reports of human use first surfaced in early 2015 after it appeared for sale on the online [[research chemical]] market. | The synthesis and pharmacology of 3-FPM was first reported in a patent filed in 2011.<ref>Blough, B. E., Rothman, R., Landavazo, A., Page, K. M., & Decker, A. M. (2017). U.S. Patent No. 9,617,229. Washington, DC: U.S. Patent and Trademark Office.</ref> Reports of human use first surfaced in early 2015 after it appeared for sale on the online [[research chemical]] market. | ||
Line 95: | Line 95: | ||
The toxicity and long-term health effects of recreational 3-FPM use do not seem to have been studied in any scientific context and the [[Toxicity::exact toxic dosage is unknown]]. This is because 3-FPM has very little history of human usage. | The toxicity and long-term health effects of recreational 3-FPM use do not seem to have been studied in any scientific context and the [[Toxicity::exact toxic dosage is unknown]]. This is because 3-FPM has very little history of human usage. | ||
Anecdotal evidence | Anecdotal evidence regarding potential toxicity is somewhat divided, with most users encountering few side-effects at low to moderate doses. However, several users have encountered serious flu-like symptoms on the comedown of 3-FPM, consisting of muscle and joint aches, fever and chills, and headaches, sometimes with migraine auras present. This is speculated to be systemic inflammation induced by 3-FPM, therefore new users should exercise great caution in dosing to gauge their own physiological response to the chemical. | ||
🤯It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance. | |||
===Tolerance and addiction potential=== | ===Tolerance and addiction potential=== | ||
As with other [[stimulant]]s, the chronic use of 3-FPM can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage. | As with other [[stimulant]]s, the chronic use of 3-FPM can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage. |